Drug intelligence / Profile preview

Lucobit

Development stage: Preclinical
Lead developer: Amvia Biotech
Administration: Oral

Overview

**Lucobit** is an oral herbal capsule developed and manufactured by Amvia Biotech for leucorrhea. The company identifies it as a herbal capsule supplied in a 30-capsule pack. Its constituent botanical ingredients, pharmacologically active compounds, molecular targets, and mechanism of action have not been publicly specified.

Brand names: Lucobit

Beyond the preview

Go deeper on Lucobit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lucobit.

Explore the full profile